Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Eli_Lilly_and_Company
gptkb:Neurimmune |
| https://www.w3.org/2000/01/rdf-schema#label |
NT-0167
|
| gptkbp:intendedUse |
gptkb:Alzheimer's_disease
|
| gptkbp:mechanismOfAction |
binds to pathological tau aggregates
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:tau_protein
|
| gptkbp:bfsParent |
gptkb:NodThera
|
| gptkbp:bfsLayer |
8
|